Search Results - "Evans, Dawna L"

  • Showing 1 - 6 results of 6
Refine Results
  1. 1

    Dopamine D4 versus D2 receptor selectivity of dopamine receptor antagonists: possible therapeutic implications by Lahti, R A, Evans, D L, Stratman, N C, Figur, L M

    Published in European journal of pharmacology (04-06-1993)
    “…The dopamine D4 receptor, which is considered a close variant of the dopamine D2 receptor, has recently been cloned. Receptor binding studies demonstrated that…”
    Get more information
    Journal Article
  2. 2

    Rat brain binding sites for pramipexole, a clinically useful D3-preferring dopamine agonist by CAMACHO-OCHOA, M, WALKER, E. L, EVANS, D. L, PIERCEY, M. F

    Published in Neuroscience letters (18-08-1995)
    “…Pramipexole (PPX) is currently being evaluated for treatment of schizophrenia and Parkinson's disease. In studies with cloned subtypes of the dopamine (DA) D2…”
    Get full text
    Journal Article
  3. 3

    Dopaminergic and serotonergic activities of imidazoquinolinones and related compounds by Moon, Malcolm W, Morris, Jeanette K, Heier, Richard F, Chidester, Connie G, Hoffmann, William E, Piercey, Montford F, Althaus, John S, VonVoigtlander, Philip F, Evans, Dawna L

    Published in Journal of medicinal chemistry (01-03-1992)
    “…The synthesis of 5-(dipropylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij] quinolin-2(1H)-one (5), a potent dopamine D2 agonist showing high dopamine/serotonin…”
    Get full text
    Journal Article
  4. 4

    Induction of c-fos mRNA in Rat Medial Prefrontal Cortex by Antipsychotic Drugs: Role of Dopamine D2 and D3 Receptors by Merchant, Kalpana M., Figur, Lana M., Evans, Dawna L.

    Published in Cerebral cortex (New York, N.Y. 1991) (01-07-1996)
    “…The present studies compared the effects of acute and chronic administration of haloperidol or clozapine on c-fos mRNA expression in the rat medial prefrontal…”
    Get full text
    Journal Article
  5. 5

    Rat brain binding sites for pramipexole, a clinically useful D 3-preferring dopamine agonist by Catnacho-Ochoa, Marlene, Walker, Erika L., Evans, Dawna L., Piercey, Montford F.

    Published in Neuroscience letters (18-08-1995)
    “…Pramipexole (PPX[ is currently being evaluated for treatment of schizophrenia and Parkinson's disease. In studies with cloned subtypes of the dopamine (DA[ D 2…”
    Get full text
    Journal Article
  6. 6

    Dopamine D2 receptor binding properties of [3H]U-86170, a dopamine receptor agonist by Lahti, R A, Evans, D L, Figur, L M, Carrigan, K J, Moon, M W, Hsi, R S

    Published in European journal of pharmacology (17-09-1991)
    “…U-86170F, an imidazoguinolinone, is a potent dopamine D2 agonist, binding with high affinity to the dopamine D2 receptor. A Kd of 0.99 nM was determined in…”
    Get more information
    Journal Article